Table 4

The incidence case number of myeloid leukemia and trend in crude incidence rates and age-standardized incidence rates per million population in the Republic of Korea from 1999 to 2018.

Years	N of cases				CIR	ASR^a)	ASR^a)
Years	Men	Women	Total	AAPC (%)	CIR	ASR^a)	AAPC (%)	IRR (per yr)
1999	696	526	1,222	3.81^b)	25.90991	26.21218	1.44^b)	1.014^b)
2000	630	542	1,172		24.65597	24.65597
2001	720	607	1,327		27.71683	27.39936
2002	806	588	1,394		28.96579	28.20531
2003	768	641	1,409		29.16678	27.92552
2004	853	658	1,511		31.16408	29.40229
2005	812	657	1,469		30.17478	28.04162
2006	839	677	1,516		31.01027	28.33077
2007	873	676	1,549		31.52837	28.48103
2008	947	743	1,690		34.20731	30.20098
2009	980	755	1,735		34.93986	30.13031
2010	1,050	748	1,798		36.04665	30.26675
2011	1,084	841	1,925		38.41435	32.02027
2012	1,060	787	1,847		36.68662	29.72320
2013	1,238	879	2,117		41.87191	32.97980
2014	1,231	862	2,093		41.23069	32.13509
2015	1,285	964	2,249		44.13983	34.03683
2016	1,384	914	2,298		44.95923	33.80285
2017	1,345	972	2,317		45.22678	32.37206
2018	1,435	990	2,425		47.27014	34.03950

^a)Calculated by defining the 2000 mid-year Korean population (July 1, 2000) as the standard population. ^b)Statistically significant trend (P< 0.05).

Abbreviations: AAPC, average annual percent change; ASR, age-standardized incidence rate; CIR, crude incidence rate; IRR, incidence rate ratio.

Blood Res 2021;56:301~314 https://doi.org/10.5045/br.2021.2021187